<DOC>
	<DOCNO>NCT03080155</DOCNO>
	<brief_summary>The purpose study assess effectiveness MIRA classify woman dense breast tissue supplemental breast MRI . To assess effectiveness MIRA correctly classify woman breast cancer evaluate safety device . In woman 30 year old undergoing MRI schedule image-guided needle biopsy due lesion detect image modality .</brief_summary>
	<brief_title>A Study 3D MIRA System Classifying Women Likelihood Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Subjects asymptomatic schedule undergo routine screening mammography OR Subjects schedule imageguided needle biopsy result finding obtain standard care image modality ( mammography , ultrasound and/or MRI ) perform clinical site participates study . 1 . Male birth . 2 . Individual le 30 great 70 year old . 3 . Contraindication bilateral mammography MRI . 4 . Subjects unable read , understand execute inform consent procedure . 5 . Subjects mammography , ultrasound MRI examination perform day study prior MIRA scan . 6 . Subjects significant exist breast trauma . 7 . Subjects undergone lumpectomy/mastectomy . 8 . Subjects undergone breast reduction breast augmentation . 9 . Subjects undergone type breast surgery . 10 . Subjects large breast scar / Breast deformation . 11 . Subjects undergone breast needle biopsy within 6month period prior intend enrollment study . 12 . Subjects temperature &gt; 37.8C degree day MIRA imaging . 13 . Subjects pregnant lactating . 14 . Subjects placement internal breast marker . 15 . Subjects know Raynaud 's Disease . 16 . Subjects claustrophobic physical limitation allow sit system chair require imaging session . 17 . Subjects implanted pacemaker/defibrillator , implant venous access device ( portacath ) implant device . 18 . Inmates ( 45 CFR 46.306 ) mentally disabled individual . 19 . Subjects BIRADS category 6 ( e.g . mammogram perform purpose planning cancer therapy ) . 20 . Subjects participate Calibration Phase able participate Testing Phase . 21 . Subjects currently participate another investigational clinical study . 22 . Subjects undergo breast MR prestaging .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>